According to a recent press release, “GraphPad Software announced today it has acquired SnapGene, a leading bioinformatics software solution. SnapGene is the easiest way to plan, visualize, and document molecular biology procedures. It was developed by Benjamin Glick, Ph.D., a professor at the University of Chicago, frustrated by inefficiencies and inadequate procedures that he experienced in research labs. Since its launch in 2012, the company has seen rapid adoption of its innovative DNA cloning solutions designed to enhance the research workflow. A parent entity, Insightful Science, was formed to support the growing portfolio of brands that now includes SnapGene. SnapGene is the second bioinformatics technology brand acquired by the company this year. Other products within the portfolio include GraphPad Prism and Geneious DNA data analysis solutions, Geneious Prime and Geneious Biologics.”
Thomas Swalla, CEO of Insightful Science, said, “We are honored to welcome SnapGene into our growing portfolio… The company has already had a phenomenal impact advancing research at leading institutions and biotech and pharmaceutical companies. We look forward to empowering even more scientists with this technology, and further serving and supporting the global scientific community.”
Benjamin Glick, Founder and Chief Scientist of SnapGene, added, “Our vision for SnapGene has always been to accelerate scientific discovery… After getting to know the team at Insightful Science, it is clear to us that they share this mission. We are proud and excited to be a part of this organization, alongside other industry-leading solutions. This partnership will help us advance our mission further.”
Read more at PR Newswire.
Image used under license from Shutterstock.com